{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:21:54Z","timestamp":1789042914726,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.cgh.2016.09.158","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T18:19:32Z","timestamp":1476209972000},"page":"575-583.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus\u2013Associated Cryoglobulinemia Treated With Direct-Acting Antivirals"],"prefix":"10.1016","volume":"15","author":[{"given":"Mart\u00edn","family":"Bonacci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabela","family":"Lens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Carlota","family":"Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Mari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Cid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramos-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mar\u00eda","family":"S\u00e1nchez-Tapias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Forns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Hern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2016.09.158_bib1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2016.09.158_bib2","first-page":"1098","article-title":"Cryoglobulinemic disease","volume":"27","author":"Retamozo","year":"2013","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.cgh.2016.09.158_bib3","doi-asserted-by":"crossref","first-page":"e68308","DOI":"10.1371\/journal.pone.0068308","article-title":"Enhanced activation of\u00a0memory, but not na\u00efve, B cells in chronic hepatitis c virus-infected patients with cryoglobulinemia and advanced liver fibrosis","volume":"8","author":"Santer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2016.09.158_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2016.09.158_bib5","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","article-title":"Cryoglobulinemia vasculitis","volume":"128","author":"Cacoub","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2016.09.158_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cgh.2016.09.158_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2014.01.029","article-title":"Diagnosis and classification of polyarteritis nodosa","volume":"48\u201349","author":"Hernandez-Rodriguez","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cgh.2016.09.158_bib8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A\u00a0randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2016.09.158_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-\u03b1\/ribavirin compared with Peg-interferon-\u03b1\/ribavirin in hepatitis C\u2013related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2016.09.158_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-\u03b1, ribavirin, and rituximab combined therapy of hepatitis C virus\u2013related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2016.09.158_bib11","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus\u2013associated mixed cryoglobulinemia vasculitis: a long-term follow-up study","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2016.09.158_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2014.08.015","article-title":"PegIFN\u03b1\/ribavirin\/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis","volume":"62","author":"Saadoun","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.09.158_bib13","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/annrheumdis-2015-208339","article-title":"Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinemia vasculitis: VASCUVALDIC study","volume":"75","author":"Saadoun","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2016.09.158_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.28297","article-title":"Treatment of hepatitis C virus-associated mixed cryoglobulinemia with sofosbuvir-based direct-acting antiviral agents","volume":"63","author":"Sise","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.09.158_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcv.2015.09.003","article-title":"Successful treatment of HCV-associated cryoglobulinemia with ombitasvir\/paritaprevir\/ritonavir, dasabuvir and ribavirin: a case report","volume":"72","author":"Makara","year":"2015","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cgh.2016.09.158_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/00325481.2015.1021660","article-title":"Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: a case series","volume":"127","author":"Cornella","year":"2015","journal-title":"Postgrad Med"},{"key":"10.1016\/j.cgh.2016.09.158_bib17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/hep.28753","article-title":"Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia","volume":"64","author":"Gragnani","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.09.158_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"European Association for Study of Liver. EASL recommendations on treatment of hepatitis C 2015","volume":"63","author":"Pawlotsky","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.09.158_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.09.158_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jhep.2012.12.028","article-title":"Update on ultrasound imaging of liver fibrosis","volume":"59","author":"Berzigotti","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.09.158_bib21","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2016.09.158_bib22","first-page":"319","article-title":"Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis","volume":"18","author":"Lamprecht","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cgh.2016.09.158_bib23","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.27623","article-title":"Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study","volume":"61","author":"Gragnani","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.09.158_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/ard.2011.150755","article-title":"Preliminary classification criteria for the cryoglobulinaemic vasculitis","volume":"70","author":"De Vita","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2016.09.158_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","article-title":"Cryoglobulinemia: a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability","volume":"40","author":"Meltzer","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2016.09.158_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MD.0b013e31829d2abc","article-title":"Impact of cryoglobulinemic syndrome on the outcome of chronic hepatitis C virus infection: a 15-year prospective study","volume":"92","author":"Lauletta","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2016.09.158_bib27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/rheumatology\/keq400","article-title":"A\u00a0cross-sectional study of the Birmingham vasculitis activity score version 3 in systemic vasculitis","volume":"50","author":"Suppiah","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.cgh.2016.09.158_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3899\/jrheum.090790","article-title":"Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy","volume":"37","author":"Landau","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cgh.2016.09.158_bib29","first-page":"128382","article-title":"Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence","volume":"2012","author":"Fabrizi","year":"2012","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.cgh.2016.09.158_bib30","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1007\/s10620-005-3059-x","article-title":"Effects of combined antiviral therapy on asymptomatic mixed cryoglobulinemia in naive patients with chronic hepatitis C virus infection: a preliminary study","volume":"50","author":"D\u2019Amico","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2016.09.158_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.23305","article-title":"Relapse of hepatitis C\u00a0virus\u2013associated mixed cryoglobulinemia vasculitis in patients with sustained viral response","volume":"58","author":"Landau","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2016.09.158_bib32","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/art.30319","article-title":"Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis","volume":"63","author":"Terrier","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2016.09.158_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0144629","article-title":"Presence of rheumatoid factor during chronic HCV infection is associated with expansion of mature activated memory B-cells that are hypo-responsive to B-cell receptor stimulation and persist during the early stage of IFN free therapy","volume":"10","author":"Reyes-Avil\u00e9s","year":"2015","journal-title":"PLoS One"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516308783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516308783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:21:14Z","timestamp":1761542474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356516308783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1542356516308783"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2016.09.158","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus\u2013Associated Cryoglobulinemia Treated With Direct-Acting Antivirals","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2016.09.158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}